Halper Sadeh LLC, a law firm focused on investor rights, has announced an investigation into three companies for potential violations of federal securities laws and breaches of fiduciary duties to shareholders. The firms under scrutiny are AlloVir, Inc. (NASDAQ: ALVR), Avid Bioservices, Inc. (NASDAQ: CDMO), and EMCORE Corporation (NASDAQ: EMKR).

The investigation centers on AlloVir's merger with Kalaris Therapeutics. Shareholders of AlloVir are encouraged to learn more about their rights and options regarding this transaction. Similarly, Avid Bioservices is being investigated in relation to its sale to GHO Capital Partners and Ampersand Capital Partners for $12.50 per share in cash. EMCORE Corporation's sale to Velocity One for $3.10 per share is also under review. Shareholders of both Avid and EMCORE are invited to explore their legal rights concerning these deals.

Halper Sadeh LLC aims to seek increased compensation for shareholders, additional disclosures, and other forms of relief. The firm operates on a contingent fee basis, meaning shareholders will not incur out-of-pocket legal fees unless the case is successful.

The firm invites affected shareholders to reach out for a free consultation to discuss their legal options. Interested parties can contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or via email.

Halper Sadeh LLC has a history of representing investors globally who have experienced securities fraud and corporate misconduct. The firm has successfully implemented corporate reforms and recovered significant amounts for defrauded investors.

For more information, shareholders can visit Halper Sadeh's website or contact the firm directly.